• Home
  • Media Events
  • Five-Week Healthcare Research Training Program Successfully Concludes at HIMS SRHU

Five-Week Healthcare Research Training Program Successfully Concludes at HIMS SRHU

Published on: February 26, 2026

The Department of Clinical Research at the Himalayan Institute of Medical Sciences (HIMS), a constituent of Swami Rama Himalayan University (SRHU), successfully concluded its five-week intensive training program titled “Ensuring Integrity of Healthcare: Good Clinical Practice and Medical Ethics,” along with a two-day Capacity Building Workshop on Healthcare Research and Biostatistics, on 26 February 2026 at the BC Roy Auditorium. Organized under the leadership of Dr. Nikku Yadav and her dedicated team, the program aimed to strengthen ethical awareness, methodological rigor, and statistical competency in healthcare research.

The valedictory ceremony commenced with the traditional lamp lighting and Guru Vandana, symbolizing the pursuit of knowledge and academic excellence. The occasion was graced by Chief Guest Dr. Piyush Agarwal, Head – Clinical Development at Dr. Reddy’s Laboratories, and Guest of Honour Dr. Vijender Chauhan, Director General (Academic Development), SRHU. Dr. Ahmadulla Shariff, Dean, HIMS, delivered the welcome address and emphasized the critical role of Good Clinical Practice, medical ethics, regulatory compliance, and robust research methodology in advancing evidence-based healthcare.

He highlighted that adherence to GCP principles ensures participant safety, data credibility, and ethical research conduct. Distinguished expert Dr. R. J. Yadav, Former Director Grade Scientist ‘G’, NIMS–ICMR, underscored the importance of high-quality data and appropriate statistical application in clinical research and project evaluation. Addressing the gathering, Dr. Vijender Chauhan reaffirmed SRHU’s commitment to promoting research that is scientifically sound, ethically responsible, and aligned with global standards of clinical practice. In his keynote address, Dr. Piyush Agarwal provided valuable insights into clinical development processes, industry expectations, and the significance of well-designed studies and accurate data interpretation in safeguarding patient welfare. The program, supported by the Department of Health Research, Ministry of Health and Family Welfare, Government of India, comprised 137 hours of structured training covering Good Clinical Practice, research ethics, regulatory frameworks, study design, and hands-on sessions using advanced research and statistical software. Sessions were conducted by distinguished experts from academia and industry, ensuring a comprehensive blend of theoretical knowledge and practical exposure.

The initiative also witnessed the presence of representatives from leading organizations such as Bharat Biotech, AstraZeneca, and Clinical Research Network India, strengthening the industry–academia interface. Certificates were distributed to participants, and 30 resource persons were recognized for their significant contributions through lectures, mentoring, and practical training. The ceremony was attended by several university dignitaries, reflecting institutional support for advancing research excellence. The event concluded with a formal vote of thanks, followed by the national anthem, group photograph, and brunch, marking the successful culmination of an intensive academic initiative dedicated to fostering ethical integrity, scientific competence, and innovation in healthcare research.

DSC_6408
DSC_6414
DSC_6419
DSC_6436
DSC_6464
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.